Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents
Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedica...
Gespeichert in:
Veröffentlicht in: | Investigative radiology 1991-05, Vol.26 (5), p.404-410 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 410 |
---|---|
container_issue | 5 |
container_start_page | 404 |
container_title | Investigative radiology |
container_volume | 26 |
creator | WOLF, GERALD L MISHKIN, MARK M ROUX, SUSAN G HALPERN, ELKAN F GOTTLIEB, JANIS ZIMMERMAN, JAY GILLEN, JOE THELLMAN, CHERYL |
description | Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication. |
doi_str_mv | 10.1097/00004424-199105000-00003 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004424_199105000_00003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2055736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3003-73b12e6b1191686b01e5f4a7923b851e447be4b7ba36e349048ee4e133e917c93</originalsourceid><addsrcrecordid>eNp1UVtLwzAUDqLMOf0JQn6A1aRJL_Ft1NtgKEx9Lkl7ulbbZiSZw1d_uZmdwxfPy-G7Bc4XhDAll5SI5Ir44TzkARWCksijYEuxAzSmEYsDElJyiMaEhCQQQsTH6MTaN-8IE8JGaBSSKEpYPEZfme5W0jRW91hX2NWAF9KB3YJp-QHGAr4x6yVegCxco3t7jWe6bwqc6d4ZaR2eLqF39mJHD8irnWp6KPGmcTV-dmB0U3qT7Ev86I1_vKfoqJKthbPdnqDXu9uX7CGYP93Psuk8KJi_LEiYoiHEilJB4zRWhEJUcZmIkKk0osB5ooCrREkWA-OC8BSAA2UMBE0KwSYoHd4tjLbWQJWvTNNJ85lTkm9bzX9bzfet_lDMR8-H6GqtOij3wV2NXueDvtGtP9W-t-sNmLwG2bo6_--z2DerFoGM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</creator><creatorcontrib>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</creatorcontrib><description><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></description><identifier>ISSN: 0020-9996</identifier><identifier>EISSN: 1536-0210</identifier><identifier>DOI: 10.1097/00004424-199105000-00003</identifier><identifier>PMID: 2055736</identifier><language>eng</language><publisher>United States: Lippincott-Raven Publishers</publisher><subject>Diatrizoate Meglumine - administration & dosage ; Diatrizoate Meglumine - adverse effects ; Humans ; Injections, Intravenous ; Iohexol - administration & dosage ; Iohexol - adverse effects ; Methylprednisolone - administration & dosage ; Methylprednisolone - therapeutic use ; Premedication ; Risk Factors ; Urography</subject><ispartof>Investigative radiology, 1991-05, Vol.26 (5), p.404-410</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2055736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WOLF, GERALD L</creatorcontrib><creatorcontrib>MISHKIN, MARK M</creatorcontrib><creatorcontrib>ROUX, SUSAN G</creatorcontrib><creatorcontrib>HALPERN, ELKAN F</creatorcontrib><creatorcontrib>GOTTLIEB, JANIS</creatorcontrib><creatorcontrib>ZIMMERMAN, JAY</creatorcontrib><creatorcontrib>GILLEN, JOE</creatorcontrib><creatorcontrib>THELLMAN, CHERYL</creatorcontrib><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><title>Investigative radiology</title><addtitle>Invest Radiol</addtitle><description><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></description><subject>Diatrizoate Meglumine - administration & dosage</subject><subject>Diatrizoate Meglumine - adverse effects</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Iohexol - administration & dosage</subject><subject>Iohexol - adverse effects</subject><subject>Methylprednisolone - administration & dosage</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Premedication</subject><subject>Risk Factors</subject><subject>Urography</subject><issn>0020-9996</issn><issn>1536-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UVtLwzAUDqLMOf0JQn6A1aRJL_Ft1NtgKEx9Lkl7ulbbZiSZw1d_uZmdwxfPy-G7Bc4XhDAll5SI5Ir44TzkARWCksijYEuxAzSmEYsDElJyiMaEhCQQQsTH6MTaN-8IE8JGaBSSKEpYPEZfme5W0jRW91hX2NWAF9KB3YJp-QHGAr4x6yVegCxco3t7jWe6bwqc6d4ZaR2eLqF39mJHD8irnWp6KPGmcTV-dmB0U3qT7Ev86I1_vKfoqJKthbPdnqDXu9uX7CGYP93Psuk8KJi_LEiYoiHEilJB4zRWhEJUcZmIkKk0osB5ooCrREkWA-OC8BSAA2UMBE0KwSYoHd4tjLbWQJWvTNNJ85lTkm9bzX9bzfet_lDMR8-H6GqtOij3wV2NXueDvtGtP9W-t-sNmLwG2bo6_--z2DerFoGM</recordid><startdate>199105</startdate><enddate>199105</enddate><creator>WOLF, GERALD L</creator><creator>MISHKIN, MARK M</creator><creator>ROUX, SUSAN G</creator><creator>HALPERN, ELKAN F</creator><creator>GOTTLIEB, JANIS</creator><creator>ZIMMERMAN, JAY</creator><creator>GILLEN, JOE</creator><creator>THELLMAN, CHERYL</creator><general>Lippincott-Raven Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199105</creationdate><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><author>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3003-73b12e6b1191686b01e5f4a7923b851e447be4b7ba36e349048ee4e133e917c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Diatrizoate Meglumine - administration & dosage</topic><topic>Diatrizoate Meglumine - adverse effects</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Iohexol - administration & dosage</topic><topic>Iohexol - adverse effects</topic><topic>Methylprednisolone - administration & dosage</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Premedication</topic><topic>Risk Factors</topic><topic>Urography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WOLF, GERALD L</creatorcontrib><creatorcontrib>MISHKIN, MARK M</creatorcontrib><creatorcontrib>ROUX, SUSAN G</creatorcontrib><creatorcontrib>HALPERN, ELKAN F</creatorcontrib><creatorcontrib>GOTTLIEB, JANIS</creatorcontrib><creatorcontrib>ZIMMERMAN, JAY</creatorcontrib><creatorcontrib>GILLEN, JOE</creatorcontrib><creatorcontrib>THELLMAN, CHERYL</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Investigative radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WOLF, GERALD L</au><au>MISHKIN, MARK M</au><au>ROUX, SUSAN G</au><au>HALPERN, ELKAN F</au><au>GOTTLIEB, JANIS</au><au>ZIMMERMAN, JAY</au><au>GILLEN, JOE</au><au>THELLMAN, CHERYL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</atitle><jtitle>Investigative radiology</jtitle><addtitle>Invest Radiol</addtitle><date>1991-05</date><risdate>1991</risdate><volume>26</volume><issue>5</issue><spage>404</spage><epage>410</epage><pages>404-410</pages><issn>0020-9996</issn><eissn>1536-0210</eissn><abstract><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></abstract><cop>United States</cop><pub>Lippincott-Raven Publishers</pub><pmid>2055736</pmid><doi>10.1097/00004424-199105000-00003</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-9996 |
ispartof | Investigative radiology, 1991-05, Vol.26 (5), p.404-410 |
issn | 0020-9996 1536-0210 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00004424_199105000_00003 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Diatrizoate Meglumine - administration & dosage Diatrizoate Meglumine - adverse effects Humans Injections, Intravenous Iohexol - administration & dosage Iohexol - adverse effects Methylprednisolone - administration & dosage Methylprednisolone - therapeutic use Premedication Risk Factors Urography |
title | Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A39%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Rates%20of%20Adverse%20Drug%20Reactions:%20Ionic%20Contrast%20Agents,%20Ionic%20Agents%20Combined%20with%20Steroids,%20and%20Nonionic%20Agents&rft.jtitle=Investigative%20radiology&rft.au=WOLF,%20GERALD%20L&rft.date=1991-05&rft.volume=26&rft.issue=5&rft.spage=404&rft.epage=410&rft.pages=404-410&rft.issn=0020-9996&rft.eissn=1536-0210&rft_id=info:doi/10.1097/00004424-199105000-00003&rft_dat=%3Cpubmed_cross%3E2055736%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2055736&rfr_iscdi=true |